The Impact of Psoriasis on the Quality of Life of Patients in San Antonio, TX
Main Article Content
Keywords
Abstract
Background: Psoriasis impacts 2% of the world’s population. The disease affects the quality of life of patients by causing pain and depression. Little information is available regarding the impact of psoriasis on San Antonio patients.
Objective: This project obtained information from patients about how they are coping with psoriasis, impact on their quality of life, barriers to care, and support systems they have.
Methods: An IRB approved six question survey was administered to 50 patients who attended the VA, a psoriasis support group, and Haven for Hope homeless clinic.
Results: 40% of patients who completed the survey had been living with psoriasis for less than 5 years. 75% of patients in this group claimed they were severely depressed. The disease impacted them most psychologically and their greatest barrier to care was access to medications that “cured” their psoriasis. 60% of the patients were living with psoriasis for more than 5 years, and 81% claimed they were not depressed at all. Psoriasis impacted them most financially and their greatest barrier was the cost of care.
Conclusion: Acutely, psoriasis patients are impacted psychologically and are frustrated with their disease. Over time, they learn to live with their condition and are impacted by the economic aspects of care.
References
2. Studzinska M, Ziemecki P, Ziemecka A, and Paryka I. The psychological and social support in patients with psoriasis. Pol Merkur Lekarski. 2013;35(207):171-174.
3. Hawro T, Miniszewska J, Chodkiewicz J, et al. Anxiety, depression and social support in patients with psoriasis. Prezgl Lek. 2007;64(9):568-571.
4. Krueger G, Koo J, Lebwohl M, et al. The Impact of Psoriasis on Quality of Life: Results of a 1998 National Psoriasis Foundation Patient-Membership Survey. Arch Dermatol.2001;137:280-284.
5. Feldman SR, Fleischer AB, Reboussin DM, et al. The economic impact of psoriasis increases with psoriasis severity. JAAD.1997;37(4):564-569.
6. Weiss SC, Kimball AB, Liewehr DJ, et al. Quantifying the harmful effect of psoriasis on health related quality of life. JAAD. 2002;47(4):512-518.
7. Gelfand JM, Feldman SR, Stern RS, Thomas J, Rolstad T, and Margolis DJ. Determinants of quality of life in patients with psoriasis: A study from the US population. JAAD. 2004;51(5):704-708.
8. Edson HE, Zhu B, Guo J, Maeda CT, and Lebwohl M. Disease burden and quality of life in psoriasis patients with and without comorbid psoriatic arthritis: results from National Psoriasis Foundation panel surveys. Cutis. 2015;95(3):173-178.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.
Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.
Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.